Novo Nordisk says generic Ozempic, Wegovy will slow sales in Canada
Novo Nordisk says the expiration of its patents for some semaglutide GLP-1 drug treatments in markets like Canada will result in more generics and hurt sales.
{*}
News, articles, comments, with a minute-by-minute update, now on Today24.pro
Today24.pro — latest news 24/7. You can add your news instantly now — here